Metabolism and effect of prostaglandin H2 in adipose tissue.
Prostaglandin H2 (PGH2) inhibited noradrenaline induced cyclic AMP accumulation in isolated rat fat cells in a dose-dependent manner. IC50 was 10-25 ng/ml both in the absence and in the presence of theophylline. The degree of inhibition produced by PGH2 increased with time of incubation. A stable PGH2 analog did not inhibit cyclic AMP accumulation. PGH2 was rapidly converted by isolated fat cells to PGD2, PGE2 and PGF2alpha' but no formation of thromboxane B2 was found either in vitro or in vivo. PGE2 was a more potent inhibitor than PGH2 of noradrenaline induced cyclic AMP accumulation. PGD2 enhanced cyclic AMP accumulation in a limited concentration interval, while PGF2alpha was essentially uneffective. Our results suggest that PGH2 is an inhibitor of cyclic AMP formation in isolated rat fat cells only after conversion to PGE2. A physiological role for PGH2 as a modulator of lipolysis is considered unlikely.
D000273:Adipose Tissue / Q000378:metabolism*; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D005990:Glycerol / Q000378:metabolism; D006880:Hydroxy Acids / Q000096:biosynthesis; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D011453:Prostaglandins / Q000378:metabolism / Q000494:pharmacology*; D011458:Prostaglandins E / Q000378:metabolism / Q000494:pharmacology; D011460:Prostaglandins F / Q000378:metabolism; D011714:Pyrans / Q000096:biosynthesis; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D006880:Hydroxy Acids; D011453:Prostaglandins; D011458:Prostaglandins E; D011460:Prostaglandins F; D011714:Pyrans; D013806:Theophylline; D000242:Cyclic AMP; D005990:Glycerol; D009638:Norepinephrine